95109 ⎘
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
NOVEL CYCLIC ACETAL COMPOUNDS WITH ALDEHYDE OR KETONE FUNCTIONALITIES AND USES THEREOF
#2SPIROCYCLIC COMPOUND CONTAINING CATALYST FOR USE IN CATALYZING REACTION OF EPOXIDE COMPOUND AND CARBON DIOXIDE
#3NOVEL CYCLIC ACETAL AND CARBONYL-CONTAINING FRAGRANCE MOLECULES
#4Hydroformylation process for producing 1,6-hexanediol derivatives
#5Photoinitiators with protected carbonyl group
#6Anthracycline Derivatives For Treating Tumor Diseases
#7Salt and photoresist composition containing the same
#8NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE
#9Process for preparing cyclic acetals which can be used as fuel components
#10Process for the industrial synthesis of sordidin
#11METHOD FOR THE PREPARATION OF THIADIAZOLES
#12Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
#13Compound
#14Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
#15Methods for preparing SGLT2 inhibitors
#16Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
#17Anthracycline derivatives for treating tumor diseases
#18SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF
#19Method for the preparation of thiadiazoles
#20Method for producing a substituted benzoic acid compound
#21Method for synthesizing sapropterin dihydrochloride
#22Method for synthesizing sapropterin dihydrochloride
#23Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#24BISPHENOL ETHER COMPOUNDS WITH NOVEL BRIDGING GROUPS AND METHODS FOR THEIR USE
#25Compound
#26Epoxidation catalysts
#27Biodegradable polymer—bioactive moiety conjugates
#28Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
#29Compound
#30Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#31Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
#32NOVEL UNSATURATED TETRACYCLIC TETRAHYDROFURAN DERIVATIVES
#33Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
#34NOVEL UNSATURATED TETRACYCLIC TETRAHYDROFURAN DERIVATIVES
#35Herbicides
#36Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
#37Nitrogen-containing compounds and harmful organism control agents
#38Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#39Fluorescent CDK inhibitors for treatment of cancer
#405-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
#41Epoxidation catalysts
#42Biodegradable polymer—bioactive moiety conjugates
#43Na channels, disease, and related assays and compositions
#44Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#45Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#46Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#47Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#48Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use
#49Glycolipid Derivative and Drug Containing the Same as Active Component
#50Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#51Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#52PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2 ALPHA DERIVATIVES
#53Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#54Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#55Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#56Process for preparation of 13,14-dihydro-PGF2 alpha derivatives
#57Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#58Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#59Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#60Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#61Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#62Ligands for metals and improved metal-catalyzed processes based thereon
#63Unsaturated tetracyclic tetrahydrofuran derivatives
#64Bicyclic cannabinoids
#65Process for the preparation of glyceraldehyde acetonide
#66Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
#67Process for the preparation of (S)-glyceraldehyde acetonide
#68Derivatization of non-natural amino acids and polypeptides
#69Therapies using non-natural amino acids and polypeptides
#70Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#71Ligands for metals and improved metal-catalyzed processes based thereon
#72Obtaining an aliphatic dialdehyde Monoacetal
#73Process for producing quinolinecarbaldehyde
#74Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate